Business constraints resulting from amendments to related regulations and laws
First written in FY2018. 1 of 2 entries say "Restated". Latest entry: FY2021.
The whole theme swung hardest in 2025: 5 of 17 companies on the "Worse" side.
16 other companies' latest entry also says "Restated".
- FY2021RestatedAnnual report
「If regulations, laws or other requirements that may relate to the Group's business are revised or newly introduced, this may require changes to service content, increase the costs of operating and maintaining services, restrict business development, or force the Group to suspend its business.」
The risk of revisions to or the introduction of related regulations, including the Medical Care Act, the Act on Securing Quality, Efficacy and Safety of Products Including Pharmaceuticals and Medical Devices, the Act on the Protection of Personal Information and the Payment Services Act, continues. - FY2018First statedAnnual report
「If regulations, laws or other requirements that may relate to the Company's business are revised or newly introduced, this may require changes to service content, increase the costs of operating and maintaining services, restrict business development, or force the Company to suspend its business.」
The Company discloses the risk that revisions to or the introduction of related regulations, including the Act against Unjustifiable Premiums and Misleading Representations, the Act on the Protection of Personal Information and the Medical Care Act, may lead to service changes, higher costs and business restrictions.